FDA Approves New Drug to Treat Psoriasis
Published by Food and Drug Administration Press Releases September 25th, 2009 in Regulatory AffairsThe U.S. Food and Drug Administration today approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis.